Item Details

Cancer Patient Access to Unapproved Treatments: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, Second Session, February 29, 1996

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations
Format
Book; Government Document
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
Language
English
ISBN
0160526124
SuDoc Number
Y 4.C 73/8:104-60
Description
iii, 71 p. ; 24 cm.
Notes
"Serial no. 104-60."
Technical Details
  • Access in Virgo Classic

  • LEADER 01517cam a2200385Ia 4500
    001 u3355048
    003 SIRSI
    008 960620s1996 dcu f000 0 eng d
    020
      
      
    a| 0160526124
    035
      
      
    a| (Sirsi) b3253065
    035
      
      
    a| b3253065
    035
      
      
    a| (OCoLC)34959357
    040
      
      
    a| GPO c| GPO
    043
      
      
    a| n-us---
    049
      
      
    a| VALU
    074
      
      
    a| 1019-A-01
    074
      
      
    a| 1019-B-01 (MF)
    086
    0
      
    a| Y 4.C 73/8:104-60
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Commerce. b| Subcommittee on Oversight and Investigations.
    245
    1
    0
    a| Cancer patient access to unapproved treatments : b| hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, February 29, 1996.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, c| 1996.
    300
      
      
    a| iii, 71 p. ; c| 24 cm.
    500
      
      
    a| "Serial no. 104-60."
    596
      
      
    a| 17
    650
      
    0
    a| Cancer x| Patients z| United States.
    650
      
    0
    a| Cancer x| Treatment z| United States.
    650
      
    0
    a| Therapeutics, Experimental z| United States.
    650
      
    0
    a| Antineoplastic agents z| United States.
    650
      
    0
    a| Clinical trials z| United States.
    941
      
      
    a| 06-29-96 b| 06-29-96 c| 1
    948
      
      
    a| 06/29/96 b| 06/29/96 c| 06/29/96
    999
      
      
    a| Y 4.C 73/8:104-60 w| SUDOC i| 35007001847338 l| LAW2-DOCS m| LAW t| DOCUMENT

Availability

Google Preview

Library Location Map Availability Call Number
Law 2nd Floor Documents Map Available